- Pembrolizumab plus enfortumab vedotin in urothelial cancer2024 | Faculty of Medicine in Pilsen
- Tumour-stroma interactions in urothelial cancer2015 | Faculty of Medicine in Pilsen
- Metabolic activation of carcinogenic aristolochic acid, a risk factor for urothelial cancer2007 | Faculty of Science
- Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines2012 | Faculty of Medicine in Pilsen
- Swedish national guidelines on urothelial cancer echo the EAU guidelines but with some regional dialect2022 | Second Faculty of Medicine
- Urothelial Cancer Stem Cell Heterogeneity2019 | Faculty of Medicine in Pilsen, Faculty of Science, First Faculty of Medicine, Faculty of Mathematics and Physics
- Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH : Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer2005 | Faculty of Science
- Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid2008 | Faculty of Science
- Is aristolochic acid a risk for Balkan endemic nephropathy-associated urothelial cancer?2002 | Faculty of Science
- Contribution of Biotransformation Enzymes to the Development of Renal Injury and Urothelial Cancer Caused by Aristolochic Acid: Urgent Questions, Difficult Answers2008 | Faculty of Science
- Triplicity of malignant tumors: urothelial cancer of the bladder, cancer of the left kidney and myelome2003 | Faculty of Medicine in Hradec Králové
- Treatment outcomes of BCG vaccine in patients with T1G3 urothelial cancer - a retrospective analysis2012 | Second Faculty of Medicine
- Strategies for the treatment of urothelial carcinoma2023 | First Faculty of Medicine
- Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer2007 | Faculty of Science
- Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer2013 | Faculty of Science
- DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer2017 | Faculty of Science
- Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria2022 | First Faculty of Medicine
- BCG - history, method principe, indication, effectivity, dosage2019 | Faculty of Medicine in Hradec Králové
- Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells2007 | Third Faculty of Medicine
- Bladder and upper urinary tract cancers as first and second primary cancers2021 | Faculty of Medicine in Pilsen
- A role of biotransformation enzymes in the Development of renal injury and urothelial cancer caused by aristolochic acid: Urgent questions difficult answers2009 | Faculty of Science
- The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers2021 | Faculty of Medicine in Pilsen
- Avelumab and its therapeutic use in uro-oncology2021 | Faculty of Medicine in Hradec Králové
- Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Rare complications post intravesical application of Bacillus-Calmette Guérin (BGG) vaccine2023 | Third Faculty of Medicine
- Chemical and molecular basis of the carcinogenicity of Aristolochia plants2009 | Faculty of Science
- Balkan endemic nephropathy: an update on its aetiology2016 | Faculty of Science
- The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia2021 | Faculty of Medicine in Pilsen
- Current status of immunotherapy in the adjuvant treatment of invasive urothelial carcinoma2023 | Faculty of Medicine in Hradec Králové
- Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study2023 | Faculty of Medicine in Pilsen